Alerts will be sent to your verified email
Verify EmailFREDUN
|
Fredun Pharma
|
Jagsonpal Pharma
|
Sakar Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.85 % | 16.01 % | 8.14 % |
|
5yr average Equity Multiplier
|
2.76 | 1.27 | 1.76 |
|
5yr Average Asset Turnover Ratio
|
1.02 | 1.09 | 0.45 |
|
5yr Avg Net Profit Margin
|
4.66 % | 12.08 % | 10.03 % |
|
Price to Book
|
5.91 | 5.42 | 6.15 |
|
P/E
|
50.38 | 34.75 | 65.47 |
|
5yr Avg Cash Conversion Cycle
|
130.49 Days | 2.39 Days | 18.72 Days |
|
Inventory Days
|
169.92 Days | 31.56 Days | 51.79 Days |
|
Days Receivable
|
77.49 Days | 15.63 Days | 53.06 Days |
|
Days Payable
|
112.96 Days | 59.94 Days | 115.64 Days |
|
5yr Average Interest Coverage Ratio
|
2.33 | 66.99 | 4.85 |
|
5yr Avg ROCE
|
27.08 % | 18.99 % | 8.92 % |
|
5yr Avg Operating Profit Margin
|
12.26 % | 13.23 % | 24.94 % |
|
5 yr average Debt to Equity
|
0.95 | 0.01 | 0.49 |
|
5yr CAGR Net Profit
|
15.87 % | 26.54 % | 10.38 % |
|
5yr Average Return on Assets
|
4.74 % | 12.71 % | 4.54 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.57 % | 69.05 % | 52.86 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-5.05 % | 0.34 % | -7.86 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Fredun Pharma
|
Jagsonpal Pharma
|
Sakar Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|